Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation

Journal of Neuroscience

Volumn 27, Issue 26, 2007, Pages 6956-6964

  Heisler, Lora K ^a   Pronchuk, Nina ^b   Nonogaki, Katsunori ^c,d   Zhou, Ligang ^a   Raber, Jacob ^e   Tung, Loraine ^a   Yeo, Giles S H ^a   O'Rahilly, Stephen ^a   Colmers, William F ^b   Elmquist, Joel K ^f   Tecott, Laurence H ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

5 HT2C receptor; Corticosterone; Corticotropin releasing hormone; mCPP; Paraventricular nucleus of the hypothalamus; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; COLCHICINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; FENFLURAMINE; MESSENGER RNA; SEROTONIN; SEROTONIN 1D RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DOWN REGULATION; GENE INACTIVATION; HISTOCHEMISTRY; HORMONAL REGULATION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULATION; THALAMUS MIDLINE NUCLEUS; WILD TYPE;

ADRENAL CORTEX HORMONES; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOWN-REGULATION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROSECRETORY SYSTEMS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTOR, SEROTONIN, 5-HT2C; RNA, MESSENGER; SEROTONIN; STRESS;

EID: 34347360837     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2584-06.2007     Document Type: Article

References (63)

1. Bagdy G, Calogero AE, Aulakh CS, Szemeredi K, Murphy DL (1989) Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. Neuroendocrinology 50:241-247.
2. Bhatnagar S, Sun LM, Raber J, Maren S, Julius D, Dallman MF (2004) Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 81:545-555.
3. Brady LS, Whitfield Jr HJ, Fox RJ, Gold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest 87:831-837.
4. Broocks A, Bandelow B, George A, Jestrabeck C, Opitz M, Bartmann U, Gleiter CH, Meineke I, Roed IS, Ruther E, Hajak G (2000) Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder. Int Clin Psychopharmacol 15:153-161.
5. Calogero AE, Bernardini R, Margioris AN, Bagdy G, Gallucci WT, Munson PJ, Tamarkin L, Tomai TP, Brady L, Gold PW, Chrousos GP (1989) Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10:189-200.
6. Calogero AE, Bagdy G, Moncada ML, D'Agata R (1993) Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol 136:381-387.
7. Cheung CC, Clifton DK, Steiner RA (1997) Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492.
8. Couceyro PR, Koylu EO, Kuhar MJ (1997) Further studies on the anatomical distribution of CART by in situ hybridization. J Chem Neuroanat 12:229-241.
9. Cowley MA, Chen C, Clarke IJ (1999a) Estrogen transiently increases delayed rectifier, voltage-dependent potassium currents in ovine gonadotropes. Neuroendocrinology 69:254-260.
10. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD (1999b) Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24:155-163.
11. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661.
12. Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mork A, Honig G, Bogeso KP, Westerink BH, den Boer H, Wikstrom HV, Tecott LH (2004) Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 29:1782-1789.
13. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK (1998) Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21:1375-1385.
14. Elmquist JK, Scammell TE, Jacobson CD, Saper CB (1996) Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 371:85-103.
15. Fuller RW, Snoddy HD (1980) Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Neuroendocrinology 31:96-100.
16. Fuller RW, Snoddy HD (1990) Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. Neuroendocrinology 52:206-211.
17. Gibbs DM, Vale W (1983) Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 280:176-179.
18. Gilbert F, Brazell C, Tricklebank MD, Stahl SM (1988) Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol 147:431-439.
19. Gold PW, Chrousos GP (1985) Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency. Psychoneuroendocrinology 10:401-419.
20. Guillemin R, Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 57:599-607.
21. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95:15049-15054.
22. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK (2002) Activation of central melanocortin pathways by fenfluramine. Science 297:609-611.
23. Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Zigman JM, Cone RD, Elmquist JK (2003) Central serotonin and melanocortin pathways regulating energy homeostasis. Ann NY Acad Sci 994:169-174.
24. Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, Liu HY, Zigman JM, Balthasar N, Kishi T, Lee CE, Aschkenasi CJ, Zhang C-Y, Yu J, Boss O, Mountjoy KG, Clifton PG, Lowell BB, Friedman JM, Horvath T, et al. (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51:239-249.
25. Herman JP, Wiegand SJ, Watson SJ (1990) Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 127:2408-2417.
26. Hoyer D (1989) 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Peripheral actions of 5-HT (Fozard J, ed), pp 72-99. Oxford: Oxford UP.
27. Hu SB, Lightman SL, Tannahill LA (1992) 5-Hydroxytryptamine stimulates corticosteroid-sensitive CRF release from cultured foetal hypothalamic cells. Role of protein kinases. Brain Res 574:266-270.
28. Javed A, Kamradt MC, Van de Kar LD, Gray TS (1999) D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala. Neuroscience 90:851-858.
29. Jorgensen H, Knigge U, Kjaer A, Muller M, Warberg J (2002) Serotonergic stimulation of corticotropin-releasing hormone and proopiomelanocortin gene expression. J Neuroendocrinol 14:788-795.
30. Kelly WF, Checkley SA, Bender DA (1980) Cushing's syndrome, tryptophan and depression. Br J Psychiatry 136:125-132.
31. Kennet GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609-620.
32. Koe KB, Nielsen JA, Macor JE, Heym J (1992) Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev Res 26:241-250.
33. Laferrere B, Lahlou N, Saltiel H, Roger M, Basdevant A, Oppert JM, Guy-Grand B (1994) Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women. Obes Res 2:328-336.
34. Laflamme N, Bovetto S, Richard D, Rivest S (1996) Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus. Br J Pharmacol 117:1021-1034.
35. Lee MD, Somerville EM, Kennett GA, Dourish CT, Clifton PG (2004) Tonic regulation of satiety by 5-HT receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies. Eur J Neurosci 19:3017-3025.
36. Li BH, Rowland NE (1993) Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull 31:43-48.
37. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van Cauter E (1987) 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65:141-152.
38. Liposits Z, Phelix C, Paull WK (1987) Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86:541-549.
39. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK (2003) Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23:7143-7154.
40. Lopez-Gimenez JF, Tecott LH, Palacios JM, Mengod G, Vilaro MT (2002) Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 67:69-85.
41. Lucki I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151-162.
42. Molineaux SM, Jessell TM, Axel R, Julius D (1989) 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86:6793-6797.
43. Nonogaki K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152-1156.
44. Nonogaki K, Ohashi-Nozue K, Oka Y (2006) A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochem Biophys Res Commun 341:703-707.
45. Pan L, Gilbert F (1992) Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology 56:797-802.
46. Paxinos G, Franklin KBJ (2001) The mouse brain, in stereotaxic coordinates, Ed 2. San Diego: Academic.
47. Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13-20.
48. Porter RJ, Gallagher P, Watson S, Young AH (2004) Corticosteroid- serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 173:1-17.
49. Pronchuk N, Beck-Sickinger AG, Colmers WF (2002) Multiple NPY receptors inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 143:535-543.
50. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247.
51. Raber J, Bloom FE (1994) IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. J Neurosci 14:6187-6195.
52. Raber J, Koob GF, Bloom FE (1995) Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272:815-824.
53. Richard D, Rivest S, Rivier C (1992) The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res 594:131-137.
54. Sawchenko PE, Swanson LW, Steinbusch HW, Verhofstad AA (1983) The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 277:355-360.
55. Sevy S, Brown SL, Wetzler S, Kotler M, Molcho A, Plutchik R, van Praag HM (1994) Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine. Psychiatry Res 53:219-229.
56. Silverstone PH, Rue JE, Franklin M, Hallis K, Camplin G, Laver D, Cowen PJ (1994) The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers. Int Clin Psychopharmacol 9:173-178.
57. Singewald N, Salchner P, Sharp T (2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275-283.
58. Spiess J, Rivier J, Rivier C, Vale W (1981) Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 78:6517- 6521.
59. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374:542-546.
60. Vielhaber K, Riemann D, Feige B, Kuelz A, Kirschbaum C, Voderholzer U (2005) Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry 38:87-94.
61. Weisstaub NV, Zhou M, Lira A, Lambe E, González-Maeso J, Hornung J-P, Sibille E, Underwood M, Itohara S, Dauer WT, Ansorge MS, Morelli E, Mann JJ, Toth M, Aghajanian G, Sealfon SC, Hen R, Gingrich JA (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313:536-540.
62. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK (2003) Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 23:2939-2946.
63. Zhang Y, Gray TS, D'Souza DN, Carrasco GA, Damjanoska KJ, Dudas B, Garcia F, Zainelli GM, Sullivan Hanley NR, Battaglia G, Muma NA, Van de Kar LD (2004) Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo. J Pharmacol Exp Ther 310:59-66.